The short version of analytical characterisation fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-12-14 and is reviewed periodically as new material appears.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.
Reported observations after unregulated use include shifts in skin pigmentation and, in some accounts, unintended changes to moles and other lesions. Whether these outcomes are causally linked to the compound, and how often they occur, remain open questions because controlled data are scarce. The absence of standardised dosing and verified product purity complicates interpretation. Researchers have called for better surveillance and analytical characterisation of samples obtained outside regulated channels. Conclusions drawn from anecdotal evidence should be treated as provisional.
Melanotan-2 has not received marketing authorisation from major regulatory agencies for any therapeutic indication. Several jurisdictions classify it as a prescription-only medicine or a controlled substance when supplied for human use. Because approved products do not exist, material sold online usually sits outside pharmaceutical supply chains and formal quality oversight. Regulators have issued public notices describing the compound as unapproved. Enforcement varies, and the legal position differs between countries, which complicates any single general statement about its status.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H69N15O9 | Synthetic cyclic heptapeptide |
| Molecular mass | Approximately 1024 g/mol | Depends on counter-ion content |
| Appearance | White to off-white powder | Commonly supplied as a lyophilised solid |
| Solubility | Freely soluble in water | Also dissolves in common aqueous buffers |
| Typical storage | -20 degrees Celsius, desiccated | Protect from light and repeated freeze-thaw |
The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.
Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
== Signs and symptoms == Often, food illnesses are not attributed to A. parasiticus because it is mistaken for A. flavus. Serious symptoms of aflatoxin exposure by either ingestion or inhalation of spores, or through direct skin contact, can occur amongst humans and animals. Signs and symptoms of exposure in humans may include delayed development and stunted growth among children, while adults may experience teratogenic effects, lung damage, ulcers, skin irritation, fever, and acute liver disease, which can later lead to liver carcinoma and death.
Charles Catania (1957), psychologist, professor at University of Maryland, Baltimore County Sheldon Saul Hendler (1957), scientist, physician, and musician Ralph Feigin (1958), pediatrician; former president and CEO of Baylor College of Medicine and physician-in-chief of Texas Children's Hospital Roald Hoffman (1958), winner of the Nobel Prize in Chemistry Norbert Hirschhorn (1958), public health physician and developed the Oral rehydration therapy Gerald T. Keusch (1958), professor of the Boston University School of Public Health and director of the John E. Fogarty International Center at the National Institutes of Health Harlan Lane (1958), professor of psychology at Northeastern University Hans Christian von Baeyer (1958), physicist at the College of William & Mary Joseph L. Fleiss (1959), professor of biostatistics at the Columbia University Mailman School of Public Health Allan Franklin (1959), physicist, historian of science at University of Colorado Boulder Paul B. Kantor (1959), information scientist, professor at Rutgers University Michael Lesch (1960), physician and medical educator who identified the Lesch–Nyhan syndrome Ira Black (1961), physician and neuroscientist, advocate of Stem cell research; former president of Society for Neuroscience Kenneth C.
SHIELD Illinois was the SHIELD Deployment Unit of the University of Illinois System charged with administering the covidSHIELD SARS-CoV-2 assay throughout the State of Illinois. SHIELD Illinois performed over 7.2 million SARS-CoV-2 assays during its initial program. This represented 12% of all SARS-CoV-2 tests in Illinois and more tests than 24 entire states.
Cleavage of proteins is an irreversible post-translational modification carried out by enzymes known as proteases. These proteases are often highly specific and cause hydrolysis of a limited number of peptide bonds within the target protein. The resulting shortened protein has an altered polypeptide chain with different amino acids at the start and end of the chain. This post-translational modification often alters the protein's function; the protein can be inactivated or activated by the cleavage and can display new biological activities.
Microneedles are constructed through various methods, usually involving photolithographic processes or micromolding. These methods involve etching microscopic structure into resin or silicon in order to cast microneedles. Microneedles are made from a variety of material ranging from silicon, titanium, stainless steel, and polymers. A variety of MNs types (solid, hollow, coated, hydrogel) has been developed to possess different functions. Some microneedles are made of a drug to be delivered to the body but are shaped into a needle so they will penetrate the skin. The microneedles range in size, shape, and function but are all used as an alternative to other delivery methods like the conventional hypodermic needle or other injection apparatus. Stimuli-responsive microneedles are advanced devices that respond to environmental triggers such as temperature, pH, or light to release therapeutic agents. The research on MNs has led to improvements in different aspects, including instruments and techniques, yet adverse events are possible in MNs users.
Sources: en.wikipedia.org
=== Potential degradation by sonication === Wang et al. reported that aqueous solutions of poloxamer 188 (Pluronic F-68) and poloxamer 407 (Pluronic F-127) sonicated in the presence or absence of multi-walled carbon nanotubes (MWNTs) can became highly toxic to cultured cells. Moreover, toxicity correlated with the sonolytic degradation of the polymers.
=== In Europe === Chia is considered a novel food in Europe because it does not have "a significant history of consumption within the European Union before 15 May 1997", according to the Advisory Committee of Novel Foods and Processes. Under this rule, chia seeds may be 5% of total matter in bread products. Prepackaged chia seeds must carry additional labelling to inform the consumer that the daily intake is no more than 15 grams and pure chia oil only 2 grams daily. Chia seeds sold in the EU are imported mainly from South American and Central American countries and require inspections for levels of pesticides, contaminants, and microbiological criteria.
== Impact == Martin Müller and Alexander Preker, writing for Der Spiegel in January 2024, have referred to Knudsen discovery in inventing the semaglutide weight-loss injections as "revolutionary", with the "drug Wegovy... [having] changed the world", and having "made Novo Nordisk Europe's most valuable company, with a greater market capitalization than Daimler, Bayer, Lufthansa and BMW combined." In the initial clinical trials for Wegovy, diabetics lost more than 10% of their weight and in trials for weight loss, patients lost an average of 12.4% of their weight. Additional patient benefits included reduction of cardiovascular events by 26%, and benefits to patients with heart and kidney failure. The GLP receptor agonists have reformed treatment outcomes for obesity and diabetes "with profound implications for maintaining human health."
National Capital Poison Center webPOISONCONTROL(R) Agency for Toxic Substances and Disease Registry American Association of Poison Control Centers American College of Medical Toxicology Clinical Toxicology Teaching Wiki Archived 2009-04-22 at the Wayback Machine Find Your Local Poison Control Centre Here (Worldwide) Poison Prevention and Education Website Cochrane Injuries Group Archived 2020-08-03 at the Wayback Machine, Systematic reviews on the prevention, treatment and rehabilitation of traumatic injury (including poisoning) Pick Your Poison—12 Toxic Tales by Cathy Newman
Sources: en.wikipedia.org
== History == Rheumasurgery emerged in the cooperation of rheumatologists and orthopedic surgeons in Heinola, Finland, during the 1950s. In 1970 a Norwegian investigation estimated that at least 50% of patients with rheumatic symptoms needed rheumasurgery as an integrated part of their treatment. The European Rheumatoid Arthritis Surgical Society (ERASS) was founded in 1979. Around the turn of the 21st century, focus for treatment of patients with rheumatic disease shifted, and pharmacological treatment became dominant, while surgical interventions became rarer.
=== Toxicity === At present, the information needed to determine if HMX causes cancer is insufficient. Due to the lack of information, EPA has determined that HMX is not classifiable as to its human carcinogenicity. The available data on the effects on human health of exposure to HMX are limited. HMX causes CNS effects similar to those of RDX, but at considerably higher doses. In one study, volunteers submitted to patch testing, which produced skin irritation. Another study of a cohort of 93 workers at an ammunition plant found no hematological, hepatic, autoimmune, or renal diseases. However, the study did not quantify the levels of exposure to HMX. HMX exposure has been investigated in several studies on animals. Overall, the toxicity appears to be quite low. HMX is poorly absorbed by ingestion. When applied to the dermis, it induces mild skin irritation but not delayed contact sensitization. Various acute and subchronic neurobehavioral effects have been reported in rabbits and rodents, including ataxia, sedation, hyperkinesia, and convulsions. The chronic effects of HMX that have been documented through animal studies include decreased hemoglobin, increased serum alkaline phosphatase, and decreased albumin. Pathological changes were also observed in the animals' livers and kidneys. Gas exchange rate was used as an indicator of chemical stress in Northern bobwhite quail (Colinus virginianus) eggs, and no evidence of alterations in metabolic rates associated with HMX exposure was observed.
Since Xi became general secretary, censorship has stepped up. Xi has overseen the increased coordination and consolidation of censorship authorities, raising their efficiency, and under his leadership censorship practices have tightened. Xi has called on for more positive energy at Chinese media, referring to the need for uplifting messages as opposed to critical or negative ones. In August 2013, he gave what became known as the August 19 speech, emphasizing the guiding role of ideology in propaganda. At the Symposium on News Reporting and Public Opinion in 2016, Xi stated that "party and government-owned media must hold the family name of the party" and that the state media "must embody the party's will, safeguard the party's authority". Xi's administration has overseen more Internet restrictions imposed, and is described as being "stricter across the board" on speech than previous administrations. In 2013, the State Internet Information Office summoned influential bloggers to a seminar to instruct them to avoid writing about politics, the CCP, or making statements contradicting official narratives. Many bloggers stopped writing about controversial topics, and Weibo went into decline, with much of its readership shifting to WeChat users speaking to limited social circles. The SIIO also formulated the Seven Bottom Lines, which serve as the bottom lines that internet users and social media companies in China must adhere to.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide and an analogue of alpha-melanocyte-stimulating hormone. The molecule is produced by chemical synthesis rather than extracted from a biological source.
It is shorter than the native hormone and carries a cyclic constraint that improves stability. These changes raise receptor potency and slow breakdown relative to the naturally occurring peptide.
Published accounts date its development to the 1980s, when researchers were generating analogues of melanocyte-stimulating hormone. That work aimed to produce more stable compounds for studying pigmentation biology.
Major regulatory agencies have not approved it for any indication. Some countries permit it only under prescription frameworks, while others classify it as a controlled substance.